Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers

Carcinogenesis

Volumn 35, Issue 11, 2014, Pages 2611-2618

  Snellenberg, Suzanne ^a   Cillessen, Saskia A G M ^a   Van Criekinge, Wim ^a,b   Bosch, Leontien ^a   Meijer, Chris J L M ^a   Snijders, Peter J F ^a   Steenbergen, Renske D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; LIPOCORTIN 5; MESSENGER RNA; PROTEIN NOXA; PUMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PRDM14; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; PRDM14 PROTEIN, HUMAN; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA BINDING MOTIF; DNA METHYLATION; ECTOPIC EXPRESSION; EMBRYO; FEMALE; GENE DELETION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; KERATINOCYTE; MOUTH CANCER; ORAL CANCER CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TUMOR ESCAPE; UPREGULATION; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; MOUTH TUMOR; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

APOPTOSIS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MOUTH NEOPLASMS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84924400196     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu197     Document Type: Article

References (49)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Bosch, F.X. et al. (2002) The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol., 55, 244-265.
3. Walboomers, J.M. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19.
4. McCredie, M.R. et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet. Oncol., 9, 425-434.
5. Wallin, K.L. et al. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med., 341, 1633-1638.
6. Winer, R.L. et al. (2005) Development and duration of human papillomavirus lesions, after initial infection. J. Infect. Dis., 191, 731-738.
7. Zielinski, G.D. et al. (2001) HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br. J. Cancer, 85, 398-404.
8. Steenbergen, R.D. et al. (2004) TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J. Natl. Cancer Inst., 96, 294-305.
9. Chen, T.M. et al. (1993) Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res., 53, 1167-1171.
10. Overmeer, R.M. et al. (2008) Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J. Pathol., 215, 388-397.
11. Wilting, S.M. et al. (2010) Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol. Cancer, 9, 167.
12. Steenbergen, R.D. et al. (2013) Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis. J. Pathol., 231, 53-62.
13. Fog, C.K. et al. (2012) PRDM proteins: important players in differentiation and disease. Bioessays, 34, 50-60.
14. Ma, Z. et al. (2011) Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates. Nat. Struct. Mol. Biol., 18, 120-127.
15. Chia, N.Y. et al. (2010) A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature, 468, 316-320.
16. Leitch, H.G. et al. (2013) Naive pluripotency is associated with global DNA hypomethylation. Nat. Struct. Mol. Biol., 20, 311-316.
17. Yamaji, M. et al. (2013) PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell, 12, 368-382.
18. Steenbergen, R.D. et al. (1996) Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene, 13, 1249-1257.
19. Steenbergen, R.D. et al. (1995) Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res., 55, 5465-5471.
20. van Zeeburg, H.J. et al. (2005) Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res., 65, 1271-1276.
21. Schmittgen, T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
22. de Wilde, J. et al. (2008) Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell. Oncol., 30, 77-87.
23. Vermes, I. et al. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184, 39-51.
24. Hess, C.J. et al. (2004) Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based method. Leukemia, 18, 1981-1988.
25. Aikawa, T. et al. (2010) Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death. FEBS Lett., 584, 681-688.
26. Han, J. et al. (2001) Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl. Acad. Sci. U. S. A., 98, 11318-11323.
27. Kreiss, P. et al. (1999) Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res., 27, 3792-3798.
28. Fadok, V.A. et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol., 148, 2207-2216.
29. Dettman, E.J. et al. (2011) Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene, 30, 2859-2873.
30. Nishikawa, N. et al. (2007) Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res., 67, 9649-9657.
31. Masuda, M. et al. (2010) CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells. J. Biol. Chem., 285, 15511-15522.
32. Voorhoeve, P.M. et al. (2003) The tumor-suppressive functions of the human INK4A locus. Cancer Cell, 4, 311-319.
33. Merlo, A. et al. (1995) 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692.
34. Esteller, M. (2008) Epigenetics in cancer. N. Engl. J. Med., 358, 1148-1159.
35. McLaughlin-Drubin, M.E. et al. (2013) Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc. Natl. Acad. Sci. U. S. A., 110, 16175-16180.
36. Boyer, S.N. et al. (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res., 56, 4620-4624.
37. Scheffner, M. et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
38. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
39. Steenbergen, R.D. et al. (2005) HPV-mediated transformation of the anogenital tract. J. Clin. Virol., 32 (suppl. 1), S25-S33.
40. Hsu, C.H. et al. (2012) The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene, 31, 2335-2349.
41. An, W. et al. (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell, 117, 735-748.
42. Burton, A. et al. (2013) Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo. Cell Rep., 5, 687-701.
43. Wilming, L.G. et al. (2008) The vertebrate genome annotation (Vega) database. Nucleic Acids Res., 36(Database issue), D753-D760.
44. Jiang, G.L. et al. (2000) The yin-yang of PR-domain family genes in tumorigenesis. Histol. Histopathol., 15, 109-117.
45. Lu, X. et al. (2013) SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells. Nat. Cell Biol., 15, 1141-1152.
46. Fuentes-González, A.M. et al. (2013) The modulation of apoptosis by oncogenic viruses. Virol. J., 10, 182.
47. Jones, P.A. et al. (2007) The epigenomics of cancer. Cell, 128, 683-692.
48. Amatori, S. et al. (2011) Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. Lung Cancer, 71, 113-115.
49. Huang, J. et al. (2011) Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets, 12, 1925-1956.